Research Information For Scientists

Glycemic Patterns and Metabolic Control: Optimizing Insulin Treatment for Type 2 Diabetes

Activity Description

Glycemic Patterns and Metabolic Control: Optimizing Insulin Treatment for Type 2 Diabetes

Albuquerque, New Mexico
Wednesday, January 25, 2012
5:45 pm - 9:00 pm
Statement of Need

Your patients with type 2 diabetes treated with insulin should monitor their blood glucose, but how often? How do you support their monitoring efforts and troubleshoot problems? How do you interpret the results? Is there a meaningful pattern? Which results do you use to adjust your patients’ insulin regimens when they are not at A1C goal or are experiencing highs or lows?

This symposium for primary care providers, who treat most people with type 2 diabetes, will teach you how to implement monitoring programs and interpret glycemic patterns to improve insulin treatment design and management in your practice. The goal is to help you better tailor insulin therapy to each patient’s individual needs, comorbidities, and self-care abilities to achieve improved glycemic control as reflected by glucose levels and A1C.

After completing this live activity, access follow-up patient visits for the case vignettes as well as a series of additional Rapid Pattern Review exercises through the Insulin Therapy Clinical Center on JPEC, the Joslin Professional Education Continuum, to further develop your skill in managing insulin treatment regimens for your patients.

Content for this activity assumes a good prerequisite knowledge of the basics of insulin treatment. If you would like to brush up on insulin treatment beforehand, please read the e-monograph Treating Diabetes with Insulin: Individualizing Therapy at http://www.joslin.org/cmeweb/CME_Mono_1892.aspx

Target Audience

This certified live activity has been developed for primary care providers. There is no fee to attend this live activity. However, space is limited, and reservations will be accepted on a first-come, first-served basis. Only clinicians can be admitted. Guests who are not clinicians cannot be accommodated.

Topics
5:45 PM Registration and Dinner
6:30 Welcome, Opening Remarks, and Preassessment Questions
6:50 Two Case Journeys: Barney and Freddy
7:50 “Rapid Pattern Recognition” Case Scenarios
8:40 Postassessment Questions and Question and Answer Session
9:00 Moderator’s Concluding Remarks and Adjournment
Learning Objectives

Participants will be provided with clinically relevant, evidence-based information.
Upon completion of this activity, participants should be able to:

  • Discuss the goals of therapy for insulin treatment of type 2 diabetes in terms of A1C and glycemic patterns
  • Describe how key changes in pathophysiology of type 2 diabetes are reflected clinically in glycemic patterns, and how this information can be used in insulin treatment design
  • Design glycemic monitoring programs to provide information needed to improve the design and management of an insulin treatment program for type 2 diabetes
  • Implement potential improvements in one’s office practice systems for support of patient monitoring program design, use, and adherence, which would provide glycemic monitoring pattern data that would improve the insulin management of type 2 diabetes

This activity has been designed to address and encourage the following IOM/ACGME Competencies:

  • Provide patient-centered care
  • Work in interdisciplinary teams
  • Employ evidence-based practice

Faculty

Speakers for this activity will be drawn from the distinguished faculty listed below.*

Richard S. Beaser, MD
Associate Clinical Professor of Medicine
Harvard Medical School
Medical Executive Director, Professional Education
Joslin Diabetes Center
Boston, MA

Lawrence Blonde, MD, FACP, FACE
Director, Ochsner Diabetes Clinical Research Unit
Ochsner Health System
New Orleans, LA

William T. Cefalu, MD
Douglas L. Manship, Sr., Professor of Diabetes
Chief, Joint Program on Diabetes, Endocrinology and Metabolism
Pennington Biomedical Research Center & LSUHSC School of Medicine
Director, Allen A. Copping Inpatient Research Unit – PBRC
Baton Rouge, LA

Kenneth R. Feingold, MD
Professor of Medicine
University of California, San Francisco
Physician and Chief, Endocrine Clinic
San Francisco VA Medical Center
San Francisco, CA

Om P. Ganda, MD
Associate Clinical Professor of Medicine
Harvard Medical School
Director, Lipid Clinic
Joslin Diabetes Center
Boston, MA

William C. Hsu, MD
Assistant Professor of Medicine
Harvard Medical School
Director, Asian Clinic
Joslin Diabetes Center
Boston, MA

Mark E. Molitch, MD
Professor of Medicine
Division of Endocrinology, Metabolism and Molecular Medicine
Northwestern University Feinberg School of Medicine
Chicago, IL

Jerry P. Palmer, MD
Director, Diabetes Endocrinology Research Center
Professor of Medicine
University of Washington
Director, Division of Endocrinology, Metabolism and Nutrition
VA Puget Sound Health Care System
Seattle, WA

John P. Sheehan, MD, FACE
Associate Clinical Professor of Medicine
Case Western Reserve University
Medical Director
North Coast Institute of Diabetes and Endocrinology, Inc.
Cleveland, OH

Kirit Tolia, MD, FACE
Clinical Associate Professor of Medicine
Wayne State University
Detroit, MI
Chief of Endocrinology and Joslin Diabetes Center Affiliate at Providence Hospital
Southfield, MI

*Faculty list subject to change

Accreditation and Designation of Credit

Joslin Diabetes Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Joslin Diabetes Center designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credits.â„¢ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This CME live activity was planned and produced in accordance with ACCME Essentials. Health professionals not eligible for continuing medical education credit will receive a certificate of participation that they may submit to their state licensing board for credit.

Disclosure Policy

It is the policy of Joslin Diabetes Center to ensure fair balance, independence, objectivity, and scientific rigor in all activities. All faculty participating in CME activities sponsored by Joslin Diabetes Center are required to present evidence-based data, identify and reference off-label product use, and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

This activity is supported by an educational grant from sanofi-aventis U.S. Inc.